At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 96 enrolled
Drug / intervention
1.5 mg of Morphine Sulfate +3 moredrug
Likely dose
1.5 mg of Morphine Sulfatefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Epidural Morphine for Geriatrics Undergoing Lower Abdominal Cancer Surgery: a Dose Response Study
In Brief
A Phase 4 clinical trial evaluating 1.5 mg of Morphine Sulfate, Normal saline, and 2 other interventions for Age Problem and Abdominal Cancer. Completed, enrolled 96 participants across 1 site.
Detailed Summary
This a clinical trial that evaluates the efficacy and safety of three different doses of morphine, namely 1.5 mg, 3 mg and 4.5 mg, via the epidural route regarding reducing pain in elderly patients after a cancer surgery in the lower abdomen
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAge Problem, Abdominal Cancer
CountriesEgypt
Collaborators--
Timeline
Phase 4CompletedFinished
202120222023202420252026
First PostedMar 2020
Enrollment StartMar 2020
Primary CompletionDec 2020
Study CompletionJun 2021
TodayJul 2026
First PostedMar 20, 2020
Enrollment StartMar 20, 2020
Primary CompletionDec 31, 2020
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.3 years ago
Interventions
1.5 mg of Morphine Sulfatedrug
1.5 mg of Morphine Sulphate will be given epidurally.
Normal salinedrug
Normal saline will be given epidurally.
3 mg of Morphine Sulfatedrug
3 mg of Morphine Sulphate will be given epidurally.
4.5 mg of Morphine Sulfatedrug
4.5 mg of Morphine Sulphate will be given epidurally.